Name | Avitinib maleate | CAS# | 1557268-88-8 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Avitinib is an orally available, irreversible, epidermal growth factor receptor (EGFR) mutant-selective inhibitor, with potential antineoplastic activity. |
Get all suppliers by the below link:
2024-07-15 |
Avitinib maleate
Price: Inquiry |
2019-03-05 |
Avitinib maleate
Price: ¥10036.0 |
2020-01-06 |
Avitinib maleate
Price: $450.0 |
2025-09-17 |
Avitinib maleate
Price: ¥Inquiry |
2023-09-26 |
Avitinib maleate
Price: ¥Inquiry |
2022-09-23 |
Avitinib maleate
Price: ¥1033.0 |
2023-11-18 |
N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide maleate
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved